Hb Nancy and Hb Osler: Two distinct genetic variants with identical clinical and hemoglobin phenotype;HB NANCY ET HB OSLER: DEUX VARIANTS DISTINCTS PARTAGEANT UN MEME PHENOTYPE CLINIQUE ET HEMOGLOBINIQUE

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 321, Issue 5, 1998, Pages 373-376

  Préhu, Claude ^a   Godart, Christian ^a   Vigneron, Claude ^b   Wajcman, Henri ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Abnormal hemoglobins; Deamidation; Erythrocytosis

Indexed keywords

ASPARTIC ACID; DNA; HEMOGLOBIN VARIANT; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; POLYCYTHEMIA;

EID: 0032077611     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(98)80300-4     Document Type: Article

References (9)

1. [1] Charache S., Brimhall B., Jones R.T., Polycythemia produced by Hemoglobin Osler (β145(HC2) Tyr→Asp), Johns Hopkins Med. J. 136 (1975) 132-136.
2. 2 145 Tyr→Asp), a new high-oxygen-affinity hemoglobin variant, Biochim. Biophys. Acta 400 (1975) 343-347.
3. [3] Gacon G., Wajcman H., Labie D., Vigneron C., Structural and functional study of Hb Nancy β145 (HC2) Tyr → Asp. A high oxygen affinity hemoglobin, FEBS Lett. 56 (1975) 39-42.
4. [4] Hutt P.J., Donaldson M.H., Khatri J., Fairbanks V.F., Hoyer J.D., Thibodeau S.N., Moxness M.S., McMorrow L.E., Green M.M., Jones R.T., Hemoglobin S/Hemoglobin Osler: A case with 3 β globin chains. DNA sequence (AAT) proves that Hb Osler is β 145 Tyr→Asn, Am. J. Hematol. 52 (1996) 305-309.
5. [5] Tyler-Cross R., Schirch V., Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides, J. Biol. Chem. 266 (1991) 22549-22556.
6. [6] Wajcman H., Kister J., Vasseur C., Blouquit Y., Trastour J.C., Cottenceau D., Galacteros F., Structure of the EF corner favors deamidation of asparaginyl residues in hemoglobin: the example of Hb La Rochesur-Yon [β81(EF5)Leu→His], Biochim. Biophys. Acta 1138 (1992) 127-132.
7. [7] Kattamis A.C., Kelly K.M., Ohene-Frempong K., Reilly M.P., Keller M., Cubeddu R., Adachi K., Surrey S., Fortina P., Hb Osler [β145(HC2) Tyr→Asp] results from posttranslational modification, Hemoglobin 21 (1997) 109-120.
8. 267(E11)Val→Met: a new unstable hemoglobin variant identified through sequencing of amplified DNA, Hemoglobin 17 (1993) 217-225.
9. [9] Rees D.C., Rochette J., Schofield C., Green B., Morris M., Parker N.E., Sasaki H., Tanaka A., Ohba Y., Clegg J.B., A novel silent posttranslational mechanism converts methionine to aspartate in hemoglobin Bristol (β67[E11] Val→Met→Asp), Blood 88 (1996) 341-348.